Equity Profile

GMED

Globus Medical, Inc.

Health CareHealth Care Equipment$11.5B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Globus Medical, Inc. is a leading company in the health care equipment sector, focusing on developing innovative solutions for spinal surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health. Investors will look for growth or surprises compared to expectations.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and increase sales, which is crucial for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Globus Medical, Inc. is a leading company in the health care equipment sector, focusing on developing innovative solutions for spinal surgery. With a market cap of $12 billion, its products are essential for improving patient outcomes and advancing surgical techniques.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

In the last quarter, Globus Medical reported an EPS of $1.12, surpassing estimates by 22%. However, the stock declined by 4.65% the following day, indicating mixed investor sentiment despite the positive earnings surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for the upcoming earnings report are cautious, given the mixed performance in the previous quarters. Investors are eager to see if the company can maintain its positive EPS surprises.

Bull Case

If Globus Medical can deliver strong revenue growth and continue its trend of beating EPS estimates, it may boost investor confidence and drive the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing demand in its spinal products, it could lead to a significant decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for this quarter, and how does it compare to last quarter's $1.12?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment and stock performance.

What insights can management provide regarding market demand for spinal products?

Understanding market demand is vital for assessing the company's growth potential and competitive position in the health care equipment sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for continued strong EPS growth, as past performance suggests a high likelihood of beating estimates.

Supporting Evidence

Globus Medical has an 88% EPS beat rate over the last eight quarters, indicating a strong track record.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a lack of confidence in performance.

The company's innovative product pipeline could drive unexpected revenue growth.

Key Risk

If the EPS comes in below $1.00, it could significantly shift market sentiment and validate bearish expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to sustain its earnings momentum and address market demand challenges.

Bull Confirmed If

An EPS of $1.20 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case and raise concerns about demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a substantial move of nearly 17%, indicating that traders expect significant volatility around the earnings announcement.

Options are pricing ±16.8% while GMED has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

This setup has occurred 30 times across Health Care in the last 2 years. 14 of 29 faded and 15 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.6%, with a raw directional average of +2.8% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Globus Medical beats expectations, history suggests the stock could see an average one-day move of +0.33%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

If the company misses earnings expectations, history suggests an average one-day move of +1.33%, indicating potential downside pressure.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on the outlook for spinal surgery demand and market conditions.
2Updates on new product launches and their expected impact on revenue.
3Insights into cost management strategies and their effect on margins.
4Discussion of competitive pressures in the health care equipment sector.
5Management's view on long-term growth prospects and market positioning.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Globus Medical, Inc. is a leading company in the health care equipment sector, focusing on developing innovative solutions for spinal surgery....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health. Investors will look for growth or surprises compared to expectations.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and increase sales, which is crucial for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

GMED Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+15.40%

Avg Stock Reaction

+0.09%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Globus Medical can deliver strong revenue growth and continue its trend of beating EPS estimates, it may boost investor confidence and drive the stock higher.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing demand in its spinal products, it could lead to a significant decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for this quarter, and how does it compare to last quarter's $1.12?

Given the company's history of beating EPS estimates, this number will be crucial for investor sentiment and stock performance.

What insights can management provide regarding market demand for spinal products?

Understanding market demand is vital for assessing the company's growth potential and competitive position in the health care equipment sector.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for continued strong EPS growth, as past performance suggests a high likelihood of beating estimates.

Supporting Evidence

Globus Medical has an 88% EPS beat rate over the last eight quarters, indicating a strong track record.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a lack of confidence in performance.

The company's innovative product pipeline could drive unexpected revenue growth.

Key Risk

If the EPS comes in below $1.00, it could significantly shift market sentiment and validate bearish expectations.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to sustain its earnings momentum and address market demand challenges.

Bull Confirmed If

An EPS of $1.20 or higher would confirm the bull case and suggest strong operational performance.

Bear Confirmed If

An EPS below $1.00 would confirm the bear case and raise concerns about demand and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±16.79%

Historical Avg

±1.7%

Pricing rich

The options market is pricing in a substantial move of nearly 17%, indicating that traders expect significant volatility around the earnings announcement.

Options are pricing ±16.8% while GMED has averaged ±1.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

42.1%

Calls (2K)P/C Ratio: 4.19Puts (4K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 14 of 29 (48%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Globus Medical beats expectations, history suggests the stock could see an average one-day move of +0.33%, confirming positive momentum.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

If the company misses earnings expectations, history suggests an average one-day move of +1.33%, indicating potential downside pressure.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any commentary on the outlook for spinal surgery demand and market conditions.
2Updates on new product launches and their expected impact on revenue.
3Insights into cost management strategies and their effect on margins.
4Discussion of competitive pressures in the health care equipment sector.
5Management's view on long-term growth prospects and market positioning.